Vaxxa AB (NGM:VAXXA)

Vaxxa AB Statistics

Total Valuation

Vaxxa AB has a market cap or net worth of SEK 22.12 million. The enterprise value is 10.19 million.

Market Cap	22.12M
Enterprise Value	10.19M

Important Dates

The next estimated earnings date is Friday, July 17, 2026.

Earnings Date	Jul 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Vaxxa AB has 43.37 million shares outstanding. The number of shares has increased by 1.08% in one year.

Current Share Class	43.37M
Shares Outstanding	43.37M
Shares Change (YoY)	+1.08%
Shares Change (QoQ)	+1.56%
Owned by Insiders (%)	3.45%
Owned by Institutions (%)	n/a
Float	41.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.27
PB Ratio	1.66
P/TBV Ratio	2.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.98
EV / Sales	0.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.02.

Current Ratio	1.13
Quick Ratio	1.07
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-230.58

Financial Efficiency

Return on equity (ROE) is -56.07% and return on invested capital (ROIC) is -34.17%.

Return on Equity (ROE)	-56.07%
Return on Assets (ROA)	-20.68%
Return on Invested Capital (ROIC)	-34.17%
Return on Capital Employed (ROCE)	-77.16%
Weighted Average Cost of Capital (WACC)	7.11%
Revenue Per Employee	10.36M
Profits Per Employee	-1.30M
Employee Count	8
Asset Turnover	2.64
Inventory Turnover	434.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.20% in the last 52 weeks. The beta is 0.51, so Vaxxa AB's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-51.20%
50-Day Moving Average	0.57
200-Day Moving Average	0.61
Relative Strength Index (RSI)	45.96
Average Volume (20 Days)	54,605

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vaxxa AB had revenue of SEK 82.89 million and -10.37 million in losses. Loss per share was -0.24.

Revenue	82.89M
Gross Profit	476,000
Operating Income	-10.38M
Pretax Income	-10.37M
Net Income	-10.37M
EBITDA	-8.13M
EBIT	-10.38M
Loss Per Share	-0.24

Balance Sheet

The company has 12.17 million in cash and 240,000 in debt, with a net cash position of 11.93 million or 0.28 per share.

Cash & Cash Equivalents	12.17M
Total Debt	240,000
Net Cash	11.93M
Net Cash Per Share	0.28
Equity (Book Value)	13.31M
Book Value Per Share	0.31
Working Capital	1.61M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	2.25M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 0.57%, with operating and profit margins of -12.52% and -12.51%.

Gross Margin	0.57%
Operating Margin	-12.52%
Pretax Margin	-12.51%
Profit Margin	-12.51%
EBITDA Margin	-9.80%
EBIT Margin	-12.52%
FCF Margin	n/a

Dividends & Yields

Vaxxa AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.08%
Shareholder Yield	-1.08%
Earnings Yield	-46.88%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 14, 2024. It was a reverse split with a ratio of 0.01.

Last Split Date	Mar 14, 2024
Split Type	Reverse
Split Ratio	0.01

Scores

Vaxxa AB has an Altman Z-Score of 4.11.

Altman Z-Score	4.11
Piotroski F-Score	n/a